Antimycin A treatment decreases respiratory internal rotenone-insensitive NADH oxidation capacity in potato leaves.
BACKGROUND
The plant respiratory chain contains several energy-dissipating enzymes, these being type II NAD(P)H dehydrogenases and the alternative oxidase, not present in mammals. The physiological functions of type II NAD(P)H dehydrogenases are largely unclear and little is known about their responses to stress. In this investigation, potato plants (Solanum tuberosum L., cv. Desiree) were sprayed with antimycin A, an inhibitor of the cytochrome pathway. Enzyme capacities of NAD(P)H dehydrogenases (EC 1.6.5.3) and the alternative oxidase were then analysed in isolated leaf mitochondria.


RESULTS
We report a specific decrease in internal rotenone-insensitive NADH dehydrogenase capacity in mitochondria from antimycin A-treated leaves. External NADPH dehydrogenase and alternative oxidase capacities remained unaffected by the treatment. Western blotting revealed no change in protein abundance for two characterised NAD(P)H dehydrogenase homologues, NDA1 and NDB1, nor for two subunits of complex I. The alternative oxidase was at most only slightly increased. Transcript levels of nda1, as well as an expressed sequence tag derived from a previously uninvestigated closely related potato homologue, remained unchanged by the treatment. As compared to the daily rhythm-regulated nda1, the novel homologue displayed steady transcript levels over the time investigated.


CONCLUSIONS
The internal rotenone-insensitive NADH oxidation decreases after antimycin A treatment of potato leaves. However, the decrease is not due to changes in expression of known nda genes. One consequence of the lower NADH dehydrogenase capacity may be a stabilisation of the respiratory chain reduction level, should the overall capacity of the cytochrome and the alternative pathway be restricted.
Geisler
Daniela A
DA
Dept of Cell and Organism Biology, Lund University, Sölvegatan 35B, Lund, (SE-223 62), Sweden. daniela.geisler@cob.lu.se
Johansson
Fredrik I
FI
Svensson
A Staffan
AS
Rasmusson
Allan G
AG
D000968:Antimycin A / Q000494:pharmacology*; D015153:Blotting, Western; D004579:Electron Transport / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D024101:Mitochondrial Proteins; D009243:NAD / Q000378:metabolism; D009245:NADH Dehydrogenase / Q000378:metabolism*; D009249:NADP / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D010088:Oxidoreductases / Q000378:metabolism*; D018515:Plant Leaves / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D010940:Plant Proteins; D012402:Rotenone / Q000494:pharmacology; D011198:Solanum tuberosum / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D013386:Succinates / Q000378:metabolism; D000099188:Alternative Oxidase
D000968:Antimycin A; D024101:Mitochondrial Proteins; D009243:NAD; D009245:NADH Dehydrogenase; D009249:NADP; D010088:Oxidoreductases; D010940:Plant Proteins; D012402:Rotenone; D013386:Succinates; D000099188:Alternative Oxidase